Physician profile
David T Plante
NPI 1467588871
$190,308.99
in general payments reported to CMS, 2019-2025
4 companies · $98K in 2025
The $98K reported for 2025 was more than what 98% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $12K · 2021: $8,455 · 2022: $1,710 · 2023: $10K · 2024: $42K · 2025: $98K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $118K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $8,130 · Food and Beverage: $2,580 · Education: $62.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $117,734.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,780.50 |
| Travel and Lodging | $8,129.86 |
| Food and Beverage | $2,579.56 |
| Education | $62.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $112,805.58 | 2019-2025 | |
| Alkermes, INC. | $37,436.96 | 2023-2025 | Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $31,179.25 | 2024-2025 | |
| Harmony Biosciences LLC | $8,887.20 | 2021-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Plante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.